Successful Treatment of Differentiated Thyroid Carcinoma with Transaxillary Robotic Surgery and Radioiodine: The First European Experience.

ABSTRACT:

Objectives

Transaxillary robotic thyroidectomy surgery (TARS) has been reported to be a safe approach in patients with differentiated thyroid carcinoma, and oncological responses are promising.

Study design

This study aimed to evaluate the oncological outcomes of TARS followed by radioiodine (RAI) therapy in patients with differentiated thyroid carcinoma. Between 2011 and 2016, patients treated for differentiated thyroid carcinoma by TARS in a single institution, followed by RAI, were retrospectively included. The oncological response was performed according to the 2015 American Thyroid Association (ATA) guidelines 6-12 months later and at the last available visit.

Results

A total of 42 patients (30 females) were included, with a median tumor size of 20 mm (12 cases o

SUBMITTER: Balay MA 

PROVIDER: S-EPMC6047495 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature